Skip to content
Home/Companies/Biotech/Adagene

Adagene

Biotech·China·Active
Entry
–
Hold
–
Status
Active

Who owns Adagene?

Adagene is currently owned by General Atlantic through General Atlantic (2020 vintage).

Hand-verified · updated 2026-04-21

General Atlantic
Investor
General Atlantic
General Atlantic · 2020 · Growth

Key facts

HQChina
SectorBiotech

More from General Atlantic

Other portfolio companies in the same fund.

58.com
Active
E-commerceChina
A-Max
A-Max
Active
Business ServicesUS
Acko
Active
TMTIndia
Aimbridge Hospitality
Aimbridge Hospitality
Active
Business ServicesUS
AKQA
AKQA
Active
TMTUK
Alignment Healthcare
Alignment Healthcare
Active
HealthTechUS

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Ariceum Therapeutics GmbH
Active
Enterprise IrelandGermany
Track Adagene

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Adagene?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Adagene.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue